Китайський виробник порошку анаболічних стероїдів
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнськаудмурт кыл

Фармацевтичні пептиди

» Пептиди » Фармацевтичні пептиди

  • Технічні характеристики
  • Опис продукту

Insulin-like growth factor 2 (IGF2) is a protein hormone known to regulate cell proliferation, growth, migration, differentiation and survival. The gene is parentally imprinted in the sense that transcripts are almost exclusively derived from the paternal allele. Loss of imprinting of the IGF2 gene is a recurrent observation in growth disorders that combine overgrowth with a variety of malignant tumours. Moreover, IGF2 has been proposed to play a role in the development of a variety of seemingly unrelated cancers that play an important role in geriatric medicine, e.g. breast cancer, colon cancer and lung cancer. Finally, IGF2 has been implicated in cardiovascular disease, since, for example, IGF2 has been shown to influence the size of atherosclerotic lesions.

IGF2 is a crucial factor for the regulation of cell proliferation, growth, migration, differentiation and survival. IGF2 (as well as IGF1) interacts with several receptors and binding proteins in order to exert its actions. It binds to the non-signaling IGF type 2 receptor (IGF2R) with high affinity. This receptor is homologous to the cation-independent mannose-6-phosphate (M6P) receptor. IGF2 can also bind to different signaling receptors, such as the IGF type 1 receptor (IGF1R) and the insulin receptor, albeit with lower affinity, although an alternatively spliced version of the insulin receptor, named insulin receptor isoform A, may bind IGF2 with higher affinity.

Both IGF1 and IGF2 are present in the circulation and can be readily detected in plasma. As might be predicted from the pattern of synthesis, circulating IGF1 levels rise during juvenile life and then decline after puberty, while circulating IGF2 levels are highest in the fetal circulation. Circulating IGFs are mostly associated with 6 specifically designed binding proteins (IGFBPs) which exhibit tissue- and stage-specific expression. In vitro, all IGFBPs inhibit the biological activity of IGFs, suggesting that part of their function may be to restrict the availability of biologically active IGFs

Форма запиту ( ми повернемося вам якомога швидше )

Ім'я:
*
Електронна пошта:
*
повідомлення:

Перевірка:
4 + 5 = ?

Можливо вам також сподобається

  • Категорії продуктів

  • Наша перевага

    Хороша ціна

    Висока якість

    Швидка доставка

    Безпечне відправлення

    Відмінне післяпродажне обслуговування

  • Місцевий склад

    Склад ЄС

    Склад Великобританії

    Склад США

    Канадський склад

    Австралійський склад

  • Спосіб оплати

    Paypal

    Bitcoin

    Банківський переказ

    Money Gram

    Вестерн юніон

  • Зв'яжіться з нами

    Електронна пошта: jacob@steroid-peptide.com

    WhatsApp: +8615636286252

    Телефон: 0086-15636286252

    Веб-сайт: www.steroid-peptide.com

    Вітаємо ваш запит

  • Сервіс